News
Treating Severe Uncontrolled Asthma: Can Single-Inhaler, Fixed Triple-Dose Therapy Improve Outcomes?
A recently approved triple-therapy combination — fluticasone furoate ... Based on the results from CAPTAIN, FF+UMEC+VI inhalation powder was approved by the US Food and Drug Administration in ...
Patients are often concerned about immunosuppressive effects of inhaled and oral corticosteroids ... In subsets of patients with COPD, high-dose fluticasone with salmeterol reduces exacerbations and ...
Kilmer died Tuesday night in Los Angeles while surrounded by family and friends, according to his daughter, Mercedes Kilmer. The company that owns the Atlanta Braves announced on Wednesday that it has ...
has accepted its New Drug Application (NDA) resubmission for YUTREPIAâ„¢ (treprostinil) inhalation powder to treat pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with ...
PRINT enabled the creation of Liquidia’s lead candidate, YUTREPIA™ (treprostinil) inhalation powder, an investigational drug for the treatment of pulmonary arterial hypertension (PAH ...
If a person has a Medicare Part D prescription drug plan, it may cover the costs of Trelegy Ellipta inhalers. Although out-of-pocket costs can vary by plan, individuals may only pay a 25% coinsurance.
Introduction Current bronchiectasis guidelines advise against the use of inhaled corticosteroids (ICS) except in patients with associated asthma, allergic bronchopulmonary aspergillosis (ABPA) and/or ...
Fluticasone propionate is a synthetic glucocorticoid used in the treatment of chronic asthma. Accurate measurement of this compound in human plasma is essential for pharmacokinetic studies and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results